Bausch Health Companies Inc
BHC7.195USD
+0.015+0.21%
收盤 12/26, 16:00（美東）報價延遲15分鐘
2.67B總市值
7.35本益比TTM
關於 Bausch Health Companies Inc 公司
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Bausch Health Companies Inc簡介
公司代碼BHC
公司名稱Bausch Health Companies Inc
上市日期Sep 20, 1994
CEOAppio (Thomas J)
員工數量20700
證券類型Ordinary Share
年結日Sep 20
公司地址2150 St. Elzear Blvd. West
城市LAVAL
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Canada
郵編H7L 4A8
電話18003611448
網址https://www.bauschhealth.com/
公司代碼BHC
上市日期Sep 20, 1994
CEOAppio (Thomas J)
Bausch Health Companies Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
627.22K
--
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
199.24K
--
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
107.66K
+1.00%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
25.38K
+212.92%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
6.60K
-97.41%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
3.67K
--
Mr. Michael Goettler
Mr. Michael Goettler
Director
Director
--
-100.00%
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
627.22K
--
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
199.24K
--
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
107.66K
+1.00%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
25.38K
+212.92%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
6.60K
-97.41%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
3.67K
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Pharmaceutical Products
4.40B
45.67%
Device Products
2.24B
23.27%
OTC
1.90B
19.77%
Branded and Other Generic Products
979.00M
10.17%
Other Product Lines
107.00M
1.11%
地區USD
名稱
營收
佔比
United States and Puerto Rico
5.77B
59.92%
Other Foreign Countries
1.08B
11.25%
China (Country)
496.00M
5.15%
Canada
402.00M
4.18%
Poland
350.00M
3.64%
其他
1.53B
15.86%
業務
地區
業務USD
名稱
營收
佔比
Pharmaceutical Products
4.40B
45.67%
Device Products
2.24B
23.27%
OTC
1.90B
19.77%
Branded and Other Generic Products
979.00M
10.17%
Other Product Lines
107.00M
1.11%
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Paulson & Co. Inc.
19.75%
Meruelo (Alex)
9.91%
GoldenTree Asset Management, LP
9.39%
Nomura Securities Co., Ltd.
4.24%
Healthcare Of Ontario Pension Plan
3.51%
其他
53.20%
持股股東
持股股東
佔比
Paulson & Co. Inc.
19.75%
Meruelo (Alex)
9.91%
GoldenTree Asset Management, LP
9.39%
Nomura Securities Co., Ltd.
4.24%
Healthcare Of Ontario Pension Plan
3.51%
其他
53.20%
股東類型
持股股東
佔比
Family Office
19.75%
Investment Advisor/Hedge Fund
14.67%
Individual Investor
10.89%
Investment Advisor
9.35%
Research Firm
7.86%
Hedge Fund
5.23%
Bank and Trust
4.46%
Pension Fund
4.11%
Private Equity
1.41%
其他
22.25%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
488
175.10M
70.29%
+43.88K
2025Q3
506
175.09M
71.73%
-42.59M
2025Q2
513
217.71M
72.26%
-4.52M
2025Q1
526
222.33M
72.55%
-45.74M
2024Q4
547
234.63M
78.06%
-1.57M
2024Q3
606
235.66M
83.60%
-25.41M
2024Q2
682
261.12M
90.70%
-4.43M
2024Q1
745
265.27M
94.42%
-80.93M
2023Q4
778
267.72M
94.93%
+4.99M
2023Q3
794
262.66M
89.53%
+17.36M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Paulson & Co. Inc.
70.76M
19.13%
+37.96M
+115.77%
Aug 14, 2025
Meruelo (Alex)
36.76M
9.94%
+148.73K
+0.41%
Mar 31, 2025
GoldenTree Asset Management, LP
34.25M
9.26%
+4.00M
+13.24%
Jun 30, 2025
Nomura Securities Co., Ltd.
21.50M
5.81%
-1.90M
-8.12%
Jun 30, 2025
Healthcare Of Ontario Pension Plan
13.00M
3.52%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
11.70M
3.16%
+23.62K
+0.20%
Jun 30, 2025
National Bank of Canada
7.74M
2.09%
+229.78K
+3.06%
Jun 30, 2025
MFN Partners Management LP
6.00M
1.62%
--
--
Jun 30, 2025
Kohlberg Kravis Roberts & Co. L.P.
5.24M
1.42%
--
--
Jun 30, 2025
RBC Brewin Dolphin
5.20M
1.41%
--
--
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
VanEck Pharmaceutical ETF
0.3%
Gotham 1000 Value ETF
0.18%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
0.12%
Schwab International Small-Cap Equity ETF
0.09%
iShares Intl Small Cap Equity Factor ETF
0.08%
DFA Dimensional International Small Cap ETF
0.07%
Schwab Fundamental International Equity ETF
0.04%
Invesco RAFI Developed Mkts ex-US ETF
0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
iShares Core MSCI International Developed Mkt ETF
0.01%
查看更多
VanEck Pharmaceutical ETF
佔比0.3%
Gotham 1000 Value ETF
佔比0.18%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
佔比0.12%
Schwab International Small-Cap Equity ETF
佔比0.09%
iShares Intl Small Cap Equity Factor ETF
佔比0.08%
DFA Dimensional International Small Cap ETF
佔比0.07%
Schwab Fundamental International Equity ETF
佔比0.04%
Invesco RAFI Developed Mkts ex-US ETF
佔比0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
佔比0.01%
iShares Core MSCI International Developed Mkt ETF
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Bausch Health Companies Inc的前五大股東是誰？
Bausch Health Companies Inc的前五大股東如下：
Paulson & Co. Inc.持有股份：70.76M佔總股份比例：19.13%。
Meruelo (Alex)持有股份：36.76M佔總股份比例：9.94%。
GoldenTree Asset Management, LP持有股份：34.25M佔總股份比例：9.26%。
Nomura Securities Co., Ltd.持有股份：21.50M佔總股份比例：5.81%。
Healthcare Of Ontario Pension Plan持有股份：13.00M佔總股份比例：3.52%。
Paulson & Co. Inc.持有股份：70.76M佔總股份比例：19.13%。
Meruelo (Alex)持有股份：36.76M佔總股份比例：9.94%。
GoldenTree Asset Management, LP持有股份：34.25M佔總股份比例：9.26%。
Nomura Securities Co., Ltd.持有股份：21.50M佔總股份比例：5.81%。
Healthcare Of Ontario Pension Plan持有股份：13.00M佔總股份比例：3.52%。
Bausch Health Companies Inc的前三大股東類型是什麼？
Bausch Health Companies Inc 的前三大股東類型分別是：
Paulson & Co. Inc.
Meruelo (Alex)
GoldenTree Asset Management, LP
Paulson & Co. Inc.
Meruelo (Alex)
GoldenTree Asset Management, LP
有多少機構持有Bausch Health Companies Inc(BHC)的股份？
截至2025Q4，共有488家機構持有Bausch Health Companies Inc的股份，合計持有的股份價值約為175.10M，占公司總股份的70.29% 。與2025Q3相比，機構持股有所增加，增幅為-1.44%。
哪個業務部門對Bausch Health Companies Inc的收入貢獻最大？
在FY2024，Pharmaceutical Products業務部門對Bausch Health Companies Inc的收入貢獻最大，創收4.40B，占總收入的45.67% 。
